Showing results (161-170 of 253) with videos related to
Sort By:
Pageof 26
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|March 12, 2014
Osteoporosis update: proceedings of the 2013 Santa Fe Bone SymposiumE Michael Lewiecki, John P Bilezikian, Lynda Bonewald, et al.The American Journal of Medicine|April 1, 2017
Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis TherapiesDavid A Hanley, Michael R McClung, K Shawn Davison, et al.Bone|February 25, 2020
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedSerge Ferrari, E Michael Lewiecki, Peter W Butler, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 31, 2012
Proceedings of the 2011 Santa Fe Bone symposiumE Michael Lewiecki, John P Bilezikian, Lawrence G Jankowski, et al.The Journal of Clinical Endocrinology and Metabolism|May 25, 2019
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentSerge Ferrari, Peter W Butler, David L Kendler, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2007
Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMDE Michael Lewiecki, Paul D Miller, Michael R McClung, et al.The Journal of Clinical Endocrinology and Metabolism|October 9, 2008
Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosisE Michael Lewiecki, Tony M Keaveny, David L Kopperdahl, et al.JBMR Plus|November 1, 2019
Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United StatesE Michael Lewiecki, Jesse D Ortendahl, Jacqueline Vanderpuye-Orgle, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 24, 2020
T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH TrialFelicia Cosman, E Michael Lewiecki, Peter R Ebeling, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 20, 2013
Osteoporosis update from the 2012 Santa Fe Bone SymposiumE Michael Lewiecki, Robert A Adler, John P Bilezikian, et al.Pageof 26